Royalty PharmaRPRX 
$24.84-1.47%24h
-1.47%24h
Global rank1462
Market cap$11.12B
Change 7d-3.76%
YTD Performance-11.25%
SP500 benchmarkUnderperform
P/E9.82
P/S4.72
Revenue$2.35B
Earnings$1.70B
Dividend yield3.2%
Main Sector
Healthcare
Royalty Pharma (RPRX) Total Liabilities
RPRX Total Liabilities in 2022: $6.30B
According to Royalty Pharma latest financial reports the total liabilities of RPRX is $6.30B, an decrease of -13.59% to 2022. At the end of 2022 company had $7.29B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Royalty Pharma is responsible for during its operational activities.
Royalty Pharma (RPRX) Total Liabilities History from 2023 to 2022
-
Value:-
RPRX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $6.30B | -13.59% |
| 2022 | $7.29B | 0.29% |
| 2021 | $7.27B | 18.66% |
| 2020 | $6.12B | -2.92% |
| 2019 | $6.31B | -3.30% |
| 2018 | $6.52B | - |
View the Top Total Liabilies Stocks
